Priya Karmali
Company: Capstan Therapeutics
Job title: Chief Technology Officer
Seminars:
Closing Remarks & End of Day One 4:45 pm
day: Day One
Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies 9:10 am
Transforming immunotherapy by enabling the reprogramming of immune cells in vivo Designing tLNPs for targeted delivery for oncology, fibrosis and inflammation-related diseases Tight control of dosage and of activity of engineered cells to achieve an advanced, first-in-class therapeuticRead more
day: Day One
Opening Remarks 8:50 am
day: Day One